Repros Therapeutics (RPRX) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $54.87 -0.76%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
PLCE, COE, JVA, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.31), $0.03 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
